miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation
出版年份 2014 全文链接
标题
miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation
作者
关键词
-
出版物
Cell Death & Disease
Volume 5, Issue 10, Pages e1445-e1445
出版商
Springer Nature
发表日期
2014-10-09
DOI
10.1038/cddis.2014.389
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced
- (2014) Abdelghani Jebahi et al. CANCER LETTERS
- Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis
- (2013) Karin Simonin et al. APOPTOSIS
- miRNA-491-5p and GIT1 Serve as Modulators and Biomarkers for Oral Squamous Cell Carcinoma Invasion and Metastasis
- (2013) W.-C. Huang et al. CANCER RESEARCH
- In-Silico Algorithms for the Screening of Possible microRNA Binding Sites and Their Interactions
- (2013) Harsh Dweep et al. CURRENT GENOMICS
- The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
- (2013) Zachary Dobbin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth
- (2013) Suvi-Katri Leivonen et al. Molecular Oncology
- Latest research and treatment of advanced-stage epithelial ovarian cancer
- (2013) Robert L. Coleman et al. Nature Reviews Clinical Oncology
- MicroRNAs and other non-coding RNAs as targets for anticancer drug development
- (2013) Hui Ling et al. NATURE REVIEWS DRUG DISCOVERY
- Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
- (2013) Peter E. Czabotar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis
- (2013) A. Vecchione et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PUMA and BIM Are Required for Oncogene Inactivation-Induced Apoptosis
- (2013) G. R. Bean et al. Science Signaling
- Influence of tumors on protective anti-tumor immunity and the effects of irradiation
- (2013) Gemma A. Foulds et al. Frontiers in Oncology
- Chemical Genomics Identifies Small-Molecule MCL1 Repressors and BCL-xL as a Predictor of MCL1 Dependency
- (2012) Guo Wei et al. CANCER CELL
- Targeting the Regulatory Machinery of BIM for Cancer Therapy
- (2012) Hisashi Harada et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- MicroRNAs: molecular features and role in cancer
- (2012) Elodie Lages Frontiers in Bioscience-Landmark
- EGFR/HER-targeted therapeutics in ovarian cancer
- (2012) Jason A Wilken et al. Future Medicinal Chemistry
- The non-coding 3' UTR of CD44 induces metastasis by regulating extracellular matrix functions
- (2012) Z. J. Rutnam et al. JOURNAL OF CELL SCIENCE
- MicroRNA miR-491-5p Targeting both TP53 and Bcl-XL Induces Cell Apoptosis in SW1990 Pancreatic Cancer Cells through Mitochondria Mediated Pathway
- (2012) Rong Guo et al. MOLECULES
- Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme
- (2011) Wei Yan et al. BRAIN RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Dual Targeting of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach in Human Ovarian Carcinoma
- (2011) C. Santiskulvong et al. CLINICAL CANCER RESEARCH
- miRNAs and regulation of cell signaling
- (2011) Atsuhiko Ichimura et al. FEBS Journal
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNAs in ovarian cancer biology and therapy resistance
- (2010) Marijn T.M. van Jaarsveld et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Targeting microRNAs in cancer: rationale, strategies and challenges
- (2010) Ramiro Garzon et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
- (2009) S. A. Bustin et al. CLINICAL CHEMISTRY
- Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications
- (2009) Delia Mezzanzanica et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-XL in colorectal cancer cells
- (2009) Haruo Nakano et al. INTERNATIONAL JOURNAL OF CANCER
- Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells
- (2009) K. Simonin et al. MOLECULAR CANCER THERAPEUTICS
- Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic
- (2008) Mark S. Cragg et al. JOURNAL OF CLINICAL INVESTIGATION
- Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
- (2008) L. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started